ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)

Purpose: We found that the combination of high-dose Methotrexate (HD-MTX)-based therapy and histone deacetylase inhibitor (HDACI) had a therapeutic effect on PCNSL. In addition, this year, tirabrutinib, a Bruton’s tyrosine kinase inhibitor, was approved for marketing as a single agent for relapsed/r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinojima, Naoki, Fujimoto, Kenji, Yamamoto, Takahiro, Ohta, Kazutaka, Takezaki, Tatsuya, Kuroda, Jun-ichiro, Makino, Keishi, Mukasa, Akitake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699052/
http://dx.doi.org/10.1093/noajnl/vdaa143.075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699052/
http://dx.doi.org/10.1093/noajnl/vdaa143.075

Ejemplares similares